Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists.
Bioorg Med Chem
; 26(1): 295-307, 2018 01 01.
Article
in En
| MEDLINE
| ID: mdl-29229226
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pyridazines
/
Sulfamerazine
/
Sulfonamides
/
Receptor, Cannabinoid, CB1
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Year:
2018
Type:
Article